India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

The Trump administration has proposed tariffs on Indian generic drugs. Per Channel NewsAsia, analysts are concerned that the tariffs could disrupt the global pharmaceutical supply chain, drive up medicine prices for Americans, and prompt Indian drugmakers to reshape their production models.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton